Immunization and Vaccine Development (IVD) SEARO
|
|
|
- Laurel Coleen Watkins
- 5 years ago
- Views:
Transcription
1 VPD Update for Week 33, 2014 Data as of 18 August 2014 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases
2 Last wild poliovirus case by type, SEAR WPV Type 2 District: Aligarh State: Uttar Pradesh (India) Date of onset: 24-Oct-1999 WPV Type 3 District: Pakur State: Jharkhand (India) Date of onset: 22-Oct-2010 WPV Type 1 District: Howrah State: West Bengal (India) Date of onset: 13-Jan-2011 Last wild poliovirus case by country Year Bangladesh 2006 Bhutan 1986 DPR Korea 1996 India 2011 Indonesia 2006 Maldives 1994 Myanmar 2007 Nepal 2010 Sri Lanka 1993 Thailand 1997 Timor-Leste 1995 *Dots are randomly placed within blocks (Sub-districts) Data as of 18 August 2014
3 Jul-13 Monthly Distribution of AFP Cases SEAR, Aug-13 Sep-13 Oct-13 Nov-13 Dec-13 Jan-14 Feb-14 Mar-14 Apr-14 May-14 Jun-14 Jul-14 Aug-14 AFP cases by month of paralysis onset, last 14 months (data from weekly case-based reports) 2013 total AFP 2014 AFP to date Date of last report Bangladesh Aug-14 Bhutan Aug-14 DPR Korea Jul-14 India Aug-14 Indonesia Aug-14 Maldives Aug-14 Myanm ar Aug-14 Nepal Aug-14 Sri Lanka Aug-14 Thailand Aug-14 Tim or-leste May-14 TOTAL Data as of 18 August 2014
4 % NPEV Vaccine Wild Primary Culture Results from AFP Cases, 2013 Polio Laboratories Number of AFP cases with specimens received in Lab Positive Culture Positive Culture + NPEV AFP cases NPEV Only Negative Pending 1 <14 days >14 days Received by lab AFP specimens % Primary Culture Reports Within 14 days Specimens from other sources 2 Number received by lab Results Bangladesh IPH, Dhaka Bhutan NIH, Bangkok DPRK NPL, Pyongyang BJMC, Ahmedabad NIV, Bangalore IoS, Kolkatta India KIPM, Chennai NCDC, Delhi CRI, Kasauli SGPGI, Lucknow ERC, Mumbai India Sub Total Bio Farma, Bandung Indonesia NIHRD, Jakarta PHL, Surabaya Indonesia Sub Total Maldives MRI, Colombo Myanmar NHL, Yangon Nepal NIH, Bangkok Sri Lanka MRI, Colombo Thailand NIH, Bangkok Timor-Leste PHL, Surabaya SEAR Calculation based on date specimen received in laboratory subtracted from date result report to the national programme. 2 Stool samples collected from contact and healthy children survey. Data as of 18 August 2014
5 % NPEV Vaccine Wild Primary Culture Results from AFP Cases, 2014 Polio Laboratories Number of AFP cases with specimens received in Lab Positive Culture Positive Culture + NPEV AFP cases NPEV Only Negative Pending 1 <14 days >14 days Received by lab AFP specimens % Primary Culture Reports Within 14 days Specimens from other sources 2 Number received by lab Results Bangladesh IPH, Dhaka Bhutan NIH, Bangkok DPRK NPL, Pyongyang BJMC, Ahmedabad NIV, Bangalore IoS, Kolkatta India KIPM, Chennai NCDC, Delhi CRI, Kasauli SGPGI, Lucknow ERC, Mumbai India Sub Total Bio Farma, Bandung Indonesia NIHRD, Jakarta PHL, Surabaya Indonesia Sub Total Maldives MRI, Colombo 0 Myanmar NHL, Yangon Nepal NIH, Bangkok Sri Lanka MRI, Colombo Thailand NIH, Bangkok Timor-Leste SEAR PHL, Surabaya Calculation based on date specimen received in laboratory subtracted from date result report to the national programme. 2 Stool samples collected from contact and healthy children survey. Data as of 18 August 2014
6 Wild Poliovirus Detected in Sewage Samples, 2013 Data (NPSP) as of 14 August 2014
7 Wild Poliovirus Detected in Sewage Samples, 2014 Data (NPSP) as of 14 August 2014
8 # Cases # Deaths # Tested for serology # Measles +ve # Rubella +ve Investigated # Cases # Deaths # Cases # Cases # Cases Neonatal Tetanus Diphtheria Pertussis Encephalitis Number of Cases of AEFI 2 Date of last report # reports expected % Completeness % Timeliness VPD Reporting, 2014 Routine Reporting of clinically suspected measles cases Suspected measles outbreaks Laboratory Confirmed 1 Number of Cases Measles Outbreaks Rubella Outbreaks Mixed Outbreaks Bangladesh NR Jul Bhutan Jul DPR Korea Mar India NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Indonesia NR NR NR 18-Jul Maldives NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Myanmar Jul Nepal NR NR Jul Sri Lanka Jul Thailand Jul Timor-Leste NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Total At least 5 blood samples should be collected and tested from each outbreak. 2 Adverse Events Follow ing Immunization; Sri Lanka AEFI data do not reflect cases but events. 3 Monthly VPD and AEFI reports due to SEARO/IVD on or before 15th of each month. NR=No report Data as of 30 June 2014
9 Measles and Rubella Serology (IgM), 2014 # % # % Bangladesh Dhaka Bhutan Thimphu DPR Korea Pyongyang India India Total Indonesia Indonesia Total Ahmedabad Bangalore Bhopal Chennai Hyderabad Jaipur Kolkata Patna Pune Bandung Jakarta Surabaya Yogyakarta Maldives Male Myanmar Yangon Nepal Kathmandu Sri Lanka Colombo Thailand Bangkok Timor-Leste Dilli NR NR NR NR NR NR NR TOTAL Laboratories Source: Reported by SEAR Measles Laboratory Netw ork 1 To be reported w ithin 4 days in in transition state Number of Serum Samples Received Number Tested NR=No Report Measles +ve Results Rubella +ve % Results Reported w ithin 7 Days 1 Data as of 30 June 2014
Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO
Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus
VPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO
VPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus cases confirmed by type,
Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO
Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus
Immunization and Vaccine Development (IVD) SEARO
Monthly Vaccine Preventable Disease and Immunization Update Published: January 03, 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus
Measles and Rubella Fact Sheet SEAR #
and Fact Sheet SEAR 8-9 Table : South-East Asia Regional (SEAR) Strategic Plan 7- Goal: To reduce the number of measles deaths by 9 in relative to estimates. Objectives: Achieve at least 9 national Containing
South-East Asia Regional Committee resolution (September 2013, New Delhi)
South-East Asia Regional Committee resolution (September 2013, New Delhi) SEAR Member States adopted the goal of measles elimination and rubella/crs control in the South-East Asia Region by 2020. Achieving
Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594
Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%
Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093
DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal
Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100
Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing
Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000
India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written
Expanded Programme on Immunization (EPI)
Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
Update on Polio Eradication in the World Health Organization South-East Asia Region, 2013
SUPPLEMENT ARTICLE Update on Polio Eradication in the World Health Organization South-East Asia Region, 2013 Patrick Michael O Connor, 1 Robert Allison, 1 Arun Thapa, 1 Sunil Bahl, 2 Supamit Chunsuittiwat,
Expanded Programme on Immunization (EPI)
Indonesia 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210
EPI history EPI launched in 980 HepB vaccine introduced in 003 AD syringes introduced in 003 HepB birth dose introduced in 004 DTP-HepB vaccine introduced in 006 MCV introduced in 008 DTP-Hib-HepB vaccine
Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)
EPI history EPI started in 978 EPI re-structured in March 000 DTP-HepB vaccine introduced in 007 DTP-Hib-HepB)vaccine introduced in 0 MR vaccine introduced in Feb 06 Second dose of MR introduced in Feb
Draft Programme (05 May 2016)
Innovations in sustainable Draft Programme (05 May 2016) Draft 7 th Meeting of the South-East Asia Region Immunization Technical Advisory Group (SEAR ITAG) 6-10 June 2016, New Delhi (India) Day 1, Monday,
Expanded Programme on Immunization (EPI)
Sri Lanka 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
Table 1: Basic information 2017
EPI history EPI launched in 978 OPV and MCV introduced in 987 AD syringes introduced in 00 HepB vaccine introduced in 003 MCV introduced partially in 008 and made available nationwide in 0 DTP-Hib-HepB
Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.
EPI history EPI launched in 978 with DPT, OPV, BCG and typhoid vaccines TT immunization of pregnant women introduced in 983 MCV introduced in 985 HepB piloted in 00 and made universal in 0 MCV introduced
IEAG Findings 5-6 December 2005
IEAG Findings 5-6 December 005 Surveillance Quality Surveillance Indicators India 005* 5.47 8% Less than 60% 60% to 69% 70% to 79% 80% and above No AFP case * data as on 6th November 005 AFP cases India
Global Measles and Rubella Update November 2018
Global Measles and Rubella Update November 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep
Eighth Meeting of the International Certification Commission for Polio Eradication for the South-East Asia Region
SEA-Polio-45 Distribution: General Eighth Meeting of the International Certification Commission for Polio Eradication for the South-East Asia Region The Report 13-15 September 2006, New Delhi, India Regional
Global Measles and Rubella Update October 2018
Global Measles and Rubella Update October 218 Measles Number of Reported Measles Cases by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug
Expanded Programme on Immunization (EPI)
Bhutan 2017 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles containing
Global Measles and Rubella Update. April 2018
Global Measles and Rubella Update April 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct
HIV Drug Resistance Surveillance and Monitoring in the Southeast Asia Region
HIV Drug Resistance Surveillance and Monitoring in the Southeast Asia Region Padmini Srikantiah, MD MPH HIV/AIDS Unit WHO- Regional Office for Southeast Asia The HIV epidemic in Southeast Asia Estimated
Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005
Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild virus type 1 Wild virus type 3 Wild virus type 1 & 3 Endemic countries Re-established transmission countries Case or outbreak following importation *Excludes
HIV Situation in South-East Asia. HIV unit Department of Communicable Diseases
HIV Situation in South-East Asia HIV unit Department of Communicable Diseases Outline Magnitude of HIV burden in South-East Asia Progress towards MDGs Regional success stories Issues and concerns Summary
Enterovirus Research Centre Mumbai. Highlights of work done
Enterovirus Research Centre Mumbai Highlights of work done -07 was the most difficult year experienced by the Enterovirus Research Centre. In the early morning hours on 21 st April, fire broke out in the
Programmatic Feasibility of Measles Elimination in South East Asia Region
Programmatic Feasibility of Elimination in South East Asia Region A. Introduction: In 2005, World Health Assembly resolution WHA58.15 endorsed the Global Immunization Vision and Strategies (GIVS) that
宮村参考人提出資料 資料 2-2
宮村参考人提出資料 資料 - Highlights of New Wild Poliovirus and cvdpv Positives Reported Globally this Week WPV cvdpv AFP other AFP other Afghanistan 5 Pakistan 3 Nigeria Location: state/province/governorate Kunar
Polio eradication. Report of the Sixth Meeting of the South-East Asia Regional Certification Commission (SEA-RCCPE) Kathmandu, November 2013
SEA-Immun-84 Distribution: General Polio eradication Report of the Sixth Meeting of the South-East Asia Regional Certification Commission (SEA-RCCPE) Kathmandu, 25 27 November 2013 World Health Organization
Polio Eradication and Surveillance. December
Polio Eradication and Surveillance December 2017 1 Acute Flaccid Paralysis (AFP) surveillance for polio eradication: >100,000 reported AFP per year December 2017 2 Global Laboratory Network for Polio Eradication
First South-East Asia Regional Technical Advisory Group on Immunization (SEAR ITAG) Meeting
SEA-Immun-17 Distribution: Limited First South-East Asia Regional Technical Advisory Group on Immunization (SEAR ITAG) Meeting A Brief Report 14 15 July 2008, Bangkok, Thailand Regional Office for South-East
Status of Outbreak Vulnerable Countries
Status of Outbreak Vulnerable Countries Hamid Jafari, WHO Robert Linkins, CDC Independent Monitoring Board Meeting 7-8 May, 2013 Outline Non-Endemic Vulnerable & At-Risk Countries Recently infected countries
International Commission for the Certification of Poliomyelitis Eradication in the South-East Asia Region
SEA-Polio-24 Distribution: General International Commission for the Certification of Poliomyelitis Eradication in the South-East Asia Region Report of the Fourth Meeting New Delhi, 21 23 March 2001 WHO
REPORT Of the FIRST SOUTH-EAST ASIA REGIONAL TECHNICAL ADVISORY GROUP ON IMMUNIZATION (SEAR ITAG) MEETING July 2008 Bangkok, Thailand
1 REPORT Of the FIRST SOUTH-EAST ASIA REGIONAL TECHNICAL ADVISORY GROUP ON IMMUNIZATION (SEAR ITAG) MEETING 14-15 July 2008 Bangkok, Thailand 2 First South-East Asia Regional Technical Advisory Group on
Polio Eradication in India. Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014
Polio Eradication in India Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014 History of Polio in India Number of Cases 200,000 200,000 OPV Introduced in RI - 1978 150,000
VPD in Mediterranean Basin and Black Sea: the Polio case
Screening practices for infectious diseases among newly arrived migrants and Vaccine Preventable Disease (VPD): strategies and coverage ISS 29 MAY 2015 VPD in Mediterranean Basin and Black Sea: the Polio
Protecting people from Vaccine Preventable Diseases
Protecting people from Vaccine Preventable Diseases Immunization and Vaccine Development South East Asia Region Strategic Plan (2010 2013) Table of Contents INTRODUCTION...2 1. THE IVD MISSION IN THE GLOBAL
TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO
TB in the SEA Region Review Plans and Progress Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO The SEA Region: 25% of the world s people, but >33% of TB patients Eastern M editerranean Region 5%
Reduction of child and maternal mortality in South-East Asia Region WHO-SEARO. UNESCAP Forum, New Delhi: 17 Feb 2012
Reduction of child and maternal mortality in South-East Asia Region WHO-SEARO 1 1 Progress in MDG 4 in SEAR Country Under 5 Mortality 2010 Target U5MR MDG 4 Status MDG4: Reduction of U5MR by two thirds
International Commission for the Certification of Poliomyelitis Eradication in the South-East Asia
SEA-Polio-30 Distribution: General International Commission for the Certification of Poliomyelitis Eradication in the South-East Asia Report of the Fifth Meeting New Delhi, India, 5-8 March 2001 WHO Project:
Progress towards achieving Millennium Development Goal 5 in South-East Asia
DOI:.1111/j.1471-528.211.38.x www.bjog.org Commentary Progress towards achieving Millennium Development Goal 5 in South-East Asia M Islam Family Health and Research, World Health Organisation, South East
Poliovirus : éradication pour les prochaines JNI?
Poliovirus : éradication pour les prochaines JNI? Bruno LINA CNR des entérovirus Laboratoire de virologie EST, GHE, HCL FRE 3011 CNRS UCBL, Lyon Polio Eradication Initiative 1 Polio Eradication Progress
Polio Eradication: Beginning of the End, or End of the Beginning?
Polio Eradication: Beginning of the End, or End of the Beginning? University of Colorado Jon Kim Andrus, MD Adjoint Professor and Director Vaccines and Immunization Center for Global Health University
Progress reports on selected Regional Committee resolutions:
REGIONAL COMMITTEE Provisional Agenda item 4.7.2 Sixty-sixth Session SEA/RC66/14 SEARO, New Delhi, India 10 13 September 2013 19 July 2013 Progress reports on selected Regional Committee resolutions: 2012:
Polio Eradication in the World Health Organization South-East Asia Region by the Year 2000: Midway Assessment of Progress and Future Challenges
S89 Polio Eradication in the World Health Organization South-East Asia Region by the Year 2000: Midway Assessment of Progress and Future Challenges Jon K. Andrus, Kaushik Banerjee, Barbara P. Hull, Jean
Current situation and capacity in the South-East Asia Region
Current situation and capacity in the South-East Asia Region Theme: Diabetes / Obesity Chandrika N Wijeyaratne Sri Lanka Medical Association TWG on Regional Action Plan on NCD Bangkok June 2013 INDICATORS
Highlighting in the WHO European Region: Summary. No. 21(February 2012)
No. 21(February 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European
Remarkable progress, new horizons and renewed commitment. Ending preventable maternal, newborn and child deaths in South-East Asia Region
Remarkable progress, new horizons and renewed commitment Ending preventable maternal, newborn and child deaths in South-East Asia Region i ii Foreword MDGs 4 and 5 inspired unprecedented efforts by countries
Report of the Regional Consultation on Measles
Report of the Regional Consultation on Measles SEARO, New Delhi, India, 25 27 August 2009 Regional Office for South-East Asia SEA-Immun-57 Distribution: General Report of the Regional Consultation on
Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,
Volume 7 Issue 5 May 2013 ISSN 1814 3601 Table 1. case classification and by country and area, WHO Western Pacific Region, 2008 2013 1 confirmed 2 2 009 per confirmed 2 2 010 2 011 2 012 2013 1 Confirmed
REGIONAL COMMITTEE Provisional Agenda item 5.3. SEA/RC64/8 Inf. Doc. Jaipur, Rajasthan, India 6 9 September August 2011
REGIONAL COMMITTEE Provisional Agenda item 5.3 Sixty-fourth Session SEA/RC64/8 Inf. Doc. Jaipur, Rajasthan, India 6 9 September 2011 2 August 2011 The attached document provides detailed and supplementary
Joint National/International Review of Acute Flaccid Paralysis (AFP) Surveillance Nepal
SEA Polio 44 Distribution: Limited Joint National/International Review of Acute Flaccid Paralysis (AFP) Surveillance Nepal 25 March 6 April 2006 and 6-12 August 2006 World Health Organization This document
Hypertension in the South-East Asia Region: an overview
Hypertension in the South-East Asia Region: an overview Anand Krishnan i, Renu Garg ii and Athula Kahandaliyanage iii Abstract Raised blood pressure or hypertension is the single most important risk factor
Global and Regional update on Polio Eradication Activities. Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018
Global and Regional update on Polio Eradication Activities Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018 Presentation Outline 1. Background information 2. Poliovirus detection & interruption
The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region
The Journal of Infectious Diseases SUPPLEMENT ARTICLE The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region Sunil Bahl, 1 Andreas Hasman, 2 Abu Obeida Eltayeb, 3 Douglas
South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) Meeting Report
The eighth meeting of the World Health Organization's South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) was held from 13 to 16 June 2017 in New Delhi, India. SEAR-ITAG is a technical
Programme Update. Transition Independent Monitoring Board London, 2 November Geneva, 23 October 2017
Programme Update Transition Independent Monitoring Board London, 2 November 2017 On Behalf of GPEI - Michel Zaffran, Director Polio Eradication, WHO Geneva, 23 October 2017 1 Polio Eradication and Endgame
POLIO ERADICATION AND POST-CERTIFICATION STRATEGY
POLIO ERADICATION AND POST-CERTIFICATION STRATEGY PRE-BOARD MEETING 5 June 2018, Geneva Reach every child www.gavi.org Agenda Topic Presenter 1. Polio eradication update WHO 10 minutes 2. IPV supply, demand
Regional Workshop for Strengthening Capacity and Internal Quality Assurance for the SEAR Measles and Rubella Laboratory Network
In order to achieve the goal of measles elimination and rubella control by 2020, case-based measles surveillance activities in all countries of South-East Asia Region, World Health Organization, have gained
AI surveillance of domestic birds in Vietnam. Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control in Asia,
AI surveillance of domestic birds in Vietnam Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control in Asia, 2008-2012 Kenji Sakurai, OIE Asia-Pacific Tokyo, 13-14 December 2012 Contents
Second Meeting of the South-East Asia Regional Verification Commission for Measles Elimination and Rubella/Congenital Rubella Syndrome Control
SEA-Immun-113 Distribution: General Second Meeting of the South-East Asia Regional Verification Commission for Measles Elimination and Rubella/Congenital Rubella Syndrome Control Colombo, Sri Lanka, 18
Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.
Global and National Trends in Vaccine Preventable Diseases Dr Brenda Corcoran National Immunisation Office Global mortality 2008 Children under 5 years of age 1.5 million deaths due to vaccine preventable
Global Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide
Global Overview Polio Partners Group, December 2015 1 Note: Gavi requirements of $122.2 million are not included in this slide The Polio Endgame Plan 1. Poliovirus detection & interruption 2. OPV2 withdrawal,
South-East Asia Regional Certification Commission for Polio Eradication (SEA-RCCPE)
SEA-Immun-107 Distribution: General South-East Asia Regional Certification Commission for Polio Eradication (SEA-RCCPE) Report of the Eighth Meeting Bali, Indonesia, 22 24 September 2015 World Health Organization
STATUS OF EAR AND HEARING CARE IN SOUTH EAST ASIA REGION
STATUS OF EAR AND HEARING CARE IN SOUTH EAST ASIA REGION Dr. Suneela Garg Director Professor, Department of Community Medicine, Maulana Azad Medical College, New Delhi, India Director - Society for Sound
WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES
WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES Immunization and vaccine development in the last decade Since the Millennium Summit in 2000, immunization substantial international
Highlighting in the WHO European Region:
No. 23(April 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European
South-East Asia Regional Certification Commission for Polio Eradication (SEARCCPE)
South-East Asia Regional Certification Commission for Polio Eradication (SEARCCPE) Report of the second meeting 25-27 January 2012, Chiang Mai, Thailand Regional Office for South-East Asia SEA-Immun-66
Progress in maternal and child health: Uzbekistan and WHO European Region
Progress in maternal and child health: Uzbekistan and WHO European Region The National Model of Maternal and Child Health Protection in Uzbekistan: Zsuzsanna Jakab WHO Regional Director for Europe UZBEKISTAN
CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN
CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN 2010-2012 14 Sept-10 2010 First and Second Quarters (January June) Geographic distribution of wild poliovirus (WPV)
HOA Outbreak Response assessment. Kenya 8 th to 12 th June 2015
HOA Outbreak Response assessment Kenya 8 th to 12 th June 2015 Subject areas of assessment Implementation of recommendation from previous assessment Quality of outbreak response AFP surveillance sensitivity
Progress reports on selected Regional Committee resolutions
REGIONAL COMMITTEE Provisional Agenda item 9 Seventy-first Session SEA/RC71/13 Rev.1 New Delhi, India 3 7 September 2018 21 August 2018 Progress reports on selected Regional Committee resolutions Progress
Global Polio Eradication & Endgame Strategy. December 2015
Global Polio Eradication & Endgame Strategy December 2015 Poliovirus detection & interruption OPV withdrawal, IPV introduction, RI strengthening Containment & Global Certification Legacy Planning Polio
SEA-Immun-105 Distribution: General. WHO South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG)
SEA-Immun-105 Distribution: General WHO South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) Report of the Seventh Meeting of SEAR-ITAG New Delhi, India, 7 10 June 2016 World Health
12-14 October 2009, WHO, Geneva
The 7 th WHO Global Measles and Rubella Laboratory Network Meeting 12-14 October 2009, WHO, Geneva Summary and Recommendations Global and Regional Update The measles and rubella laboratory network (LabNet)
AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO
POLIO FAQs on ENDGAME Tuberculosis AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO OBJECTIVES Brief history of poliomyelitis Polio eradication:
TB-HIV in the South-East Asia Region
TB-HIV in the South-East Asia Region 13 th Core Group Meeting of the TB/HIV Working Group April 17-18 New York, USA Dr Nani Nair Regional Advisor-TB TB and HIV in South-East Asia Outline Epidemiology of
Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage
A MONTHLY NEWSLETTER OF THE COMMUNICABLE DISEASE UNIT, WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE, COPENHAGEN, DENMARK Issue 5, March 2009 Analysis of 3-dose oral/inactivated poliovirus vaccine
Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance
Flu Watch MMWR Week 3: January 14 to January 2, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.
Update on Status of Wild Poliovirus Outbreak in Kenya. 9 th Meeting of the IMB 1-3 October 2013 London, UK
Update on Status of Wild Poliovirus Outbreak in Kenya 9 th Meeting of the IMB 1-3 October 2013 London, UK Contents Background Confirmation and Immediate Response High Risk Areas Coordination of Response
Update on Progress and Challenges in Achieving Measles and Rubella Targets
Update on Progress and Challenges in Achieving Measles and Rubella Targets SAGE Meeting 6 November 2013 P. Strebel, WHO/IVB/EPI Overview Global progress Regional updates Summary 2 Measles and Rubella Targets
Measles & rubella outbreaks in Maharashtra State, India
Indian J Med Res 143, February 2016, pp 227-231 DOI:10.4103/0971-5916.180214 Measles & rubella outbreaks in Maharashtra State, India Sunil R. Vaidya, Madhukar B. Kamble, Deepika T. Chowdhury & Neelakshi
Hepatitis E Vaccine Clinical Experience. Mrigendra P. Shrestha
Hepatitis E Vaccine Clinical Experience Mrigendra P. Shrestha 1 Hepatitis E in Nepal 2 Hepatitis E in Nepal Most common type of acute viral hepatitis Occurs in annual rainy season outbreaks Responsible
Syndromic Surveillance in Integrated Disease Surveillance Project (IDSP) and Pre Hospital Emergency Care in India
Syndromic Surveillance in Integrated Disease Surveillance Project (IDSP) and Pre Hospital Emergency Care in India Vivek V. Singh Public Health Foundation of India (PHFI) Presentation structure Background
Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance
Flu Watch MMWR Week 4: January 21 to January 27, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.
Durham Region Influenza Bulletin: 2017/18 Influenza Season
Durham Region Influenza Bulletin: 2017/18 Influenza Season Surveillance Week 21 (May 20, 2018 to May 26, 2018) Table 1: Assessment of influenza activity in Durham Region Measure Laboratory confirmed cases
WHO/SEAR Technical Consultative Group on Polio Eradication
SEA-Polio-25 Distribution: General WHO/SEAR Technical Consultative Group on Polio Eradication Report of a Special Meeting Yangon,, 29-31 May 2001 WHO Project: ICP VAB 001 World Health Organization Regional
Drug resistance in tuberculosis in South-East Asia
Drug resistance in tuberculosis in South-East Asia Vineet Bhatia*, Md Khurshid Alam Hyder* and Nani Nair* Abstract The South-East Asia Region (SEAR) of WHO bears around one third of the global burden of
VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE 7. 7
VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE IMMUNISATION PROGRAMME IN 2002 7. 7 The childhood immunisation programme in Singapore offers vaccination against tuberculosis, hepatitis B, diphtheria,
SOUTH-EAST ASIA ACTION PLAN
SOUTHEAST ASIA ACTION PLAN 20162020 Cover Photos by: Ist Row: Ministry of Public Health Democratic People s Republic of Korea WHO/Bangladesh/R Kumar WHO/Bhutan WHO/India/R Kumar IInd Row: Ministry of Health/Epidemiology
FMD Control Initiatives in Bangladesh
FMD Control Initiatives in Bangladesh Dr. Md. Mohsin Ali Dr. Md. Ainul Haque Department of Livestock Services, Bangladesh Country Profile In Short Bangladesh is a Republic of South Asia It is bordered
All photographs used on the cover page are from WHO sources.
WHO Library Cataloguing-in-Publication data World Health Organization, Regional Office for South-East Asia. Achieving the health-related Millennium Development Goals in the South-East Asia region: Measuring
Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 March 2018, WHO Western Pacific Region
Volume 12 Issue 4 April ISSN 1814 3601 Figure 1. Incidence rate of total ( compatible) measles cases with rash onset 1 31 ch, WHO Western Pacific Region Legend: No cases
Regional workshop on surveillance standards for measles, rubella and priority vaccine-preventable diseases
SEA-Immun-108 Distribution: General Regional workshop on surveillance standards for measles, rubella and priority vaccine-preventable diseases Kathmandu, Nepal, 19 23 September 2016 World Health Organization
National Xpert MTB/RIF Programme
National Xpert MTB/RIF Programme 1. Background to Project This project was initiated at the request of the Honorable Minister of Health, Dr Aaron Motsoaledi, in early 2011, following the World Health Organization
Report of the Seventh Meeting SEAR- ITAG
WHO South East Asia Regional - Immunization Technical Advisory Group (SEAR- ITAG) Report of the Seventh Meeting SEAR- ITAG New, 7 to 10 June 2016 i Table of contents Contents Page Table of contents ii